Form 4: Merck & Co. Director Douglas M. Baker Jr. Reports Transaction in Phantom Stock

Director Douglas M. Baker Jr. reports a transaction involving phantom stock units of Merck & Co., to be settled in cash upon termination of service.

Summary

• On May 31, 2024, Douglas M. Baker Jr., a director of Merck & Co., reported a transaction involving phantom stock.
• Baker acquired 1,752.4295 units of phantom stock at a price of $125.54.
• These phantom stock units are to be settled 100% in cash upon Baker's termination of service, according to the terms of the Plan for Deferred Payment of Directors' Compensation.
• Baker also disposed of 1,000 shares of common stock.
• Following the reported transaction, Baker directly owns 6,281.5136 derivative securities.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, indicating neutral sentiment. It reports a transaction without expressing any positive or negative outlook.

Future Outlook

The phantom stock units will be settled in cash upon the reporting person's termination of service, according to the distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

Industry Context

Form 4 filings are standard practice for reporting transactions by company insiders, providing transparency to investors regarding their trading activities.

Stakeholder Impact

• Shareholders are informed about the director's transactions in the company's securities, promoting transparency.

Key Dates